Italy· 043855093

ALGALT

A oxycodone and naloxone product containing ossicodone (oxicodone) cloridrato/naloxone cloridrato diidrato, registered in Italy by EG S.P.A., on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC N02AA55

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedALGALTATCN02AA55REGISTER NO.043855093PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Oxycodone and naloxone is registered in 12 of 19 countries.

Countries holding a registration under ATC N02AA55 (oxycodone and naloxone), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 8 of them publish a price we can compare per daily dose

Oxycodone and naloxone · ATC N02AA55

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxycodone and naloxone costs, country by country.

Normalised to the WHO defined daily dose (75 mg), so markets compare like for like.

  • Italy: $6.34 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Oxycodone and naloxone · price per daily dose (75 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$6.49
  • IT Italy$6.34
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Ossicodone (oxicodone) cloridrato/naloxone cloridrato diidrato
Manufacturer
EG S.P.A.
Country
Italy (IT)
ATC code
N02AA55
ATC class
Oxycodone and naloxone
Defined daily dose
75 mg, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    043855093
    "20 MG/10 MG COMPRESSE A RILASCIO PROLUNGATO" 28 COMPRESSE IN BLISTER AL/PVC/PE/PVDC
    EUR 20.78

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for oxycodone and naloxone.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oxycodone and naloxone · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/570c0552-cc07-4e4f-9351-50e9c860807b
GET /v1/drugs/570c0552-cc07-4e4f-9351-50e9c860807b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"20 MG/10 MG COMPRESSE A RILASCIO PROLUNGATO\" 28 COMPRESSE IN BLISTER   AL/PVC/PE/PVDC",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Ossicodone (oxicodone) cloridrato/naloxone cloridrato diidrato",
  "reference_pack": "28 UNITA' (20+10) MG - USO ORALE RILASCIO PROLUNGATO",
  "public_price_eur": 20.78,
  "ssn_reference_price_eur": 25.12
}

See everything about oxycodone and naloxone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.